Predicting Multi-Drug Resistance in Bacterial Isolates Through Performance Comparison and LIME-based Interpretation of Classification Models

Fuente: arXiv
Salvato in:
Dettagli Bibliografici
Autori principali: Wishal, Santanam, Sahara, Riad
Natura: Preprint
Pubblicazione: 2026
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866908858454114304
author Wishal, Santanam
Sahara, Riad
author_facet Wishal, Santanam
Sahara, Riad
contents The rise of Antimicrobial Resistance, particularly Multi-Drug Resistance (MDR), presents a critical challenge for clinical decision-making due to limited treatment options and delays in conventional susceptibility testing. This study proposes an interpretable machine learning framework to predict MDR in bacterial isolates using clinical features and antibiotic susceptibility patterns. Five classification models were evaluated, including Logistic Regression, Random Forest, AdaBoost, XGBoost, and LightGBM. The models were trained on a curated dataset of 9,714 isolates, with resistance encoded at the antibiotic family level to capture cross-class resistance patterns consistent with MDR definitions. Performance assessment included accuracy, F1-score, AUC-ROC, and Matthews Correlation Coefficient. Ensemble models, particularly XGBoost and LightGBM, demonstrated superior predictive capability across all metrics. To address the clinical transparency gap, Local Interpretable Model-agnostic Explanations (LIME) was applied to generate instance-level explanations. LIME identified resistance to quinolones, Co-trimoxazole, Colistin, aminoglycosides, and Furanes as the strongest contributors to MDR predictions, aligning with known biological mechanisms. The results show that combining high-performing models with local interpretability provides both accuracy and actionable insights for antimicrobial stewardship. This framework supports earlier MDR identification and enhances trust in machine learning-assisted clinical decision support.
format Preprint
id arxiv_https___arxiv_org_abs_2602_22400
institution arXiv
publishDate 2026
record_format arxiv
spellingShingle Predicting Multi-Drug Resistance in Bacterial Isolates Through Performance Comparison and LIME-based Interpretation of Classification Models
Wishal, Santanam
Sahara, Riad
Machine Learning
The rise of Antimicrobial Resistance, particularly Multi-Drug Resistance (MDR), presents a critical challenge for clinical decision-making due to limited treatment options and delays in conventional susceptibility testing. This study proposes an interpretable machine learning framework to predict MDR in bacterial isolates using clinical features and antibiotic susceptibility patterns. Five classification models were evaluated, including Logistic Regression, Random Forest, AdaBoost, XGBoost, and LightGBM. The models were trained on a curated dataset of 9,714 isolates, with resistance encoded at the antibiotic family level to capture cross-class resistance patterns consistent with MDR definitions. Performance assessment included accuracy, F1-score, AUC-ROC, and Matthews Correlation Coefficient. Ensemble models, particularly XGBoost and LightGBM, demonstrated superior predictive capability across all metrics. To address the clinical transparency gap, Local Interpretable Model-agnostic Explanations (LIME) was applied to generate instance-level explanations. LIME identified resistance to quinolones, Co-trimoxazole, Colistin, aminoglycosides, and Furanes as the strongest contributors to MDR predictions, aligning with known biological mechanisms. The results show that combining high-performing models with local interpretability provides both accuracy and actionable insights for antimicrobial stewardship. This framework supports earlier MDR identification and enhances trust in machine learning-assisted clinical decision support.
title Predicting Multi-Drug Resistance in Bacterial Isolates Through Performance Comparison and LIME-based Interpretation of Classification Models
topic Machine Learning
url https://arxiv.org/abs/2602.22400